Cancer Mortality in Women with Thyroid Disease

Cancer Research

Volumn 50, Issue 8, 1990, Pages 2283-2289

  Goldman, Marlene B ^a   Monson, Richard R ^a   Maloof, Farahe ^b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER MORTALITY; CAUSE OF DEATH; FATALITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; THYROID DISEASE;

ADENOMA; ADULT; BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; GOITER; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; MIDDLE AGE; NEOPLASMS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; THYROID DISEASES; THYROIDITIS, AUTOIMMUNE;

EID: 0025240347     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Loeser, A. A. A new therapy for prevention of post-operative recurrences in genital and breast cancer. A six-years study of prophylactic thyroid treatment. Br. Med. J., 2: 1380–1383, 1954.
2. Ellerker, A. G. Thyroid disorders and breast cancer. A causal connection? Med. Press, 235: 280–282, 1956.
3. Itoh, K., and Maruchi, N. Breast cancer in patients with Hashimoto's thyroiditis. Lancet, 2: 1119–1121, 1975.
4. Kurland, L. T., and Annegers, J. F. Breast cancer and Hashimoto's thyroiditis. Lancet, 1: 808, 1976.
5. Edelstyn, G. A., Lyons, A. R., and Welbourn, R. B. Thyroid function in patients with mammary cancer. Lancet, 1: 670–671, 1958.
6. Backwinkel, K., and Jackson, A. S. Some features of breast cancer and thyroid deficiency. Cancer (Phila.), 17: 1174–1176, 1964.
7. McCormack, K. R., and Sheline, G. E. Leukemia after radioiodine therapy for hyperthyroidism. Calif. Med., 98: 207–209, 1963.
8. Kennedy, W. M., and Fish, R. G. Acute granulocytic leukemia after radioactive-iodine therapy for hyperthyroidism. N. Engl. J. Med., 260: 76–77, 1959.
9. Bundi, R. S., Scott, J. S., and Hainan, K. E. Chronic myeloid leukemia following radioiodine therapy for carcinoma thyroid. Br. J. Radiol., 50: 61–64, 1977.
10. Araki, M., and Oshiro, K. Papillary adenocarcinoma of the thyroid developing after treatment of hyperthyroidism with 131-I. Gann, 61: 267–269, 1970.
11. Kreps, E. M., Kreps, S. M., and Kreps, S. I. Treatment of hyperthyroidism with sodium iodide I 131. Carcinoma of the thyroid after 20 years. JAMA, 226: 774–775, 1973.
12. McDougall, I. R. Thyroid cancer after iodine-131 therapy. JAMA, 227: 438, 1974.
13. Donovan, J. W., and Adelstein, A. M. Multiple-cause analysis of deaths of patients treated with radio-iodine. Br. J. Prev. Soc. Med., 28: 69, 1974.
14. Warner, T. F. C. S., and Peralta, J. Multifocal adenocarcinoma of the jejunum. Cancer (Phila.), 44: 1142–1145, 1979.
15. Munoz, J. M., Gorman, C. A., Elveback, L. R., and Wentz, J. R. Incidence of malignant neoplasms of all types in patients with Graves' disease. Arch. Intern. Med., 138: 944–947, 1978.
16. Hoffman, D. A., McConahey, W. M., Fraumeni, J. F., Jr., and Kurland, L. T. Cancer incidence following treatment of hyperthyroidism. Int. J. Epidemiol., 11: 218–224, 1982.
17. Goldman, M. B., Maloof, F., Monson, R. R., Aschengrau, A., Cooper, D. S., and Ridgway, E. C. Radioactive iodine therapy and breast cancer: a follow-up study of hyperthyroid women. Am. J. Epidemiol., 127: 969–980, 1988.
18. Kapdi, C. C., and Wolfe, J. N. Breast cancer. Relationship to thyroid supplements for hypothyroidism. JAMA, 236: 1124–1127, 1976.
19. Gorman, C. A., Becker, D. V., Greenspan, F. S., Levy, R. P., Oppenheimer, J. H., Rivlin, R. S., Robbins, J., and VanderLaan, W. P. American Thyroid Association Statement. Breast cancer and thyroid hormone therapy. Ann. Intern. Med., 86: 502–503, 1977.
20. World Health Organization, Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death. WHO, Geneva, 8th Revision, 1967.
21. Monson, R. R. Analysis of relative survival and proportional mortality. Comput. Biomed. Res., 7: 325–332, 1974.
22. Rothman, K. J., and Boice, J. D. Epidemiologic Analysis with a Programmable Calculator, p. 29. Boston: Epidemiology Resources, Inc., 1982.
23. Saenger, E. L., Thoma, G. E., and Tompkins, E. A. Incidence of leukemia following treatment of hyperthyroidism. Preliminary report of the Cooperative Thyrotoxicosis Therapy Follow-up Study. JAMA, 205: 855–862, 1968.
24. Dobyns, B. M., Sheline, G. E., Workman, J. B., Tompkins, E. A., McConahey, W. M., and Becker, D. V. Malignant and benign neoplasms of the thyroid in patients treated for hyperthyroidism: a report of the Cooperative Thyrotoxicosis Therapy Follow-up Study. J. Clin. Endocrinol. Metab., 38: 976–988, 1974.
25. Vena, J. E., Sultz, H. A., Carlo, G. L., Fiedler, R. C., and Barnes, R. E. Sources of bias in retrospective cohort mortality studies: a note on treatment of subjects lost to follow-up. J. Occup. Med., 29: 256–261, 1987.
26. Shapiro, S., Slone, D., Kaufman, D. W., Rosenberg, L., Miettinen, O. S., Stolley, P. D., Knapp, R. C., Leavitt, T., Watring, W. G., Rosenshein, N. B., and Schottenfeld, D. Use of thyroid supplements in relation to the risk of breast cancer. JAMA, 244: 1685–1687, 1980.
27. Hoffman, D. A., McConahey, W. M., Brinton, L. A., and Fraumeni, J. F., Jr., Breast cancer in hypothyroid women using thyroid supplements. JAMA, 257: 616–619, 1984.
28. Holm, L. E., Blongren, H., and Lowhagen, T. Cancer risks in patients with chronic lymphocytic thyroiditis. N. Engl. J. Med., 312: 601–604, 1985.
29. Kato, I., Tajima, K., Suchi, T., Aozasa, K., Matsuzuka, F., Kuma, K., and Tominaga, S. Chronic thyroiditis as a risk factor of B-cell lymphoma in the thyroid gland. Jpn. J. Cancer Res., 76: 1085–1090, 1985.
30. Fukuda, A., Hirohata, T., Noguchi, S., Ikeda, M., Matsuo, K., and Yoshida, A. Risks for malignancies in patients with chronic thyroiditis: a long-term follow-up study. Jpn. J. Cancer Res., 78: 1329–1334, 1987.
31. Haines, A. P., Moss, A. R., Whittemore, A., and Quivey, J. A case-control study of pancreatic carcinoma. J. Cancer Res. Clin. Oncol., 103: 93–97, 1982.